Vanda V. West-Ward: This Time, Dosage Adjustment Claims Are Patent Eligible Subject Matter | Latest News RSS feed

Vanda V. West-Ward: This Time, Dosage Adjustment Claims Are Patent Eligible Subject Matter - Latest News


Treatment Method Patents After Fed. Circ. Vanda Ruling

The Federal Circuit in Vanda held the method claims at issue,[4] directed to treating patients with schizophrenia, patent-eligible under ... “Recent Subject Matter Eligibility Decision: Vanda Pharmace... read more

Avadel Pharmaceuticals plc (AVDL)

patents and proprietary rights associated with the Drug may not provide adequate protection; patents licensed to us under our license agreement with Serenity that cover the Drug are subject to litigat... read more

Avadel Pharmaceuticals plc (AVDL)

On June 2, 2017, Avadel Pharmaceuticals plc (the "Company") furnished to the holders of its ... of shareholders which is scheduled to be held at 12:00 Noon (Irish Standard Time) on Wednesday, June 28, ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us